Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Galera Therapeutics (GRTX) shares
Learn how to easily invest in Galera Therapeutics shares.
Galera Therapeutics is a biotechnology business based in the US. Galera Therapeutics stocks (GRTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $10.09 – a decrease of 15.18% over the previous week. Galera Therapeutics employs 38 staff and has a market cap (total outstanding stock value) of $90.9 million.
How to buy shares in Galera Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GRTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Galera Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Galera Therapeutics?
- Has coronavirus impacted Galera Therapeutics shares?
- Galera Therapeutics shares summary
- Compare share dealing platforms
- Is Galera Therapeutics stock a buy or sell?
- Galera Therapeutics performance over time
- Galera Therapeutics's financials
- How volatile are Galera Therapeutics shares?
- Does Galera Therapeutics pay a dividend?
- Other common questions
How has Coronavirus impacted Galera Therapeutics's stock price?
Since the stock market crash in March caused by coronavirus, Galera Therapeutics's stock price has had significant negative movement.
Its last market close was $2.85, which is 82.03% down on its pre-crash value of $15.86 and 95.79% down on the lowest point reached during the March crash when the stocks fell as low as $5.58.
If you had bought $1,000 worth of Galera Therapeutics stocks at the start of February 2020, those stocks would have been worth $631.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $215.75.
Galera Therapeutics stock price (NASDAQ:GRTX)Use our graph to track the performance of GRTX stocks over time.
Galera Therapeutics shares at a glance
|Latest market close||$2.85|
|52-week range||$1.19 - $12.99|
|50-day moving average||$2.60|
|200-day moving average||$6.50|
|Wall St. target price||$15.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.30|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Galera Therapeutics price performance over time
|1 week (2022-01-12)||-15.18%|
|1 month (2021-12-17)||-3.72%|
|3 months (2021-10-19)||26.67%|
|6 months (2021-07-19)||-68.47%|
|1 year (2021-01-19)||-71.92%|
|2 years (2020-01-17)||-78.76%|
|3 years (2019-01-15)||N/A|
|5 years (2017-01-15)||N/A|
Galera Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-49.41%|
|Return on equity TTM||-1063.11%|
|Market capitalisation||$90.9 million|
TTM: trailing 12 months
Galera Therapeutics share dividends
We're not expecting Galera Therapeutics to pay a dividend over the next 12 months.
Galera Therapeutics share price volatility
Over the last 12 months, Galera Therapeutics's shares have ranged in value from as little as $1.19 up to $12.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galera Therapeutics's is 1.9771. This would suggest that Galera Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Galera Therapeutics overview
Galera Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which is in Phase III clinical trial for the treatment of radiation-induced severe oral mucositis in patients with head and neck cancer (HNC); and in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; in phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy; and has completed pilot placebo-controlled Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) for patients with locally advanced pancreatic cancer, as well as in Phase II clinical trial for hospitalized patients with COVID-19 disease. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with SBRT in patients with non-small cell lung cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. .
Frequently asked questions
Galera Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.